MCGRATH YVONNE (VP, Research and Development) sold 7.93K shares of ITEOS THERAPEUTICS, INC. on the open market
Open‑market sale worth $158.5K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/10/2021ACC: 0000899243-21-023000
Officer· VP, Research and Development
Since Jul 2020
-7.93K
Net shares
Net seller
$158.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
7.93K acquired · 15.85K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.93K
Price / share
$4.23
Trade value
$33.53K
% of position
New position
6/8/2021
0.00→7.93K
Common Stock
Direct
Shares
−7.93K
Price / share
$20.00
Trade value
$158.54K
% of position
New position
6/8/2021
7.93K→0.00
Total
Net shares
+0.00
Net value
-$125.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/8/2021 | M · Option Exercise | +7.93K | $4.23 | $33.53K | New position | 0.00 | 7.93K |
| Common Stock Direct | 6/8/2021 | S · Sale | −7.93K | $20.00 | $158.54K | New position | 7.93K | 0.00 |
| Total | +0.00 | -$125.01K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1.40K shares
Shares
−7.93K
Strike price
4.23
Held after
95.12K
Exercisable
—
6/8/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1.40K shares | 6/8/2021 | M · Option Exercise | −7.93K | 4.23 | — | 95.12K |